|Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond|
S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ...
JAMA oncology 1 (1), 23-32, 2015
|A clinically applicable molecular-based classification for endometrial cancers|
A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ...
British journal of cancer 113 (2), 299-310, 2015
|Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer|
A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ...
Cancer 123 (5), 802-813, 2017
|Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series|
S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ...
Annals of Oncology 29 (5), 1180-1188, 2018
|Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas|
MK McConechy, A Talhouk, HH Li-Chang, S Leung, DG Huntsman, ...
Gynecologic oncology 137 (2), 306-310, 2015
|New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care|
A Talhouk, JN McAlpine
Gynecologic oncology research and practice 3 (1), 1-12, 2016
|Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis|
MK McConechy, A Talhouk, S Leung, D Chiu, W Yang, J Senz, ...
Clinical Cancer Research 22 (12), 2865-2873, 2016
|Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment|
A Talhouk, LN Hoang, MK McConechy, Q Nakonechny, J Leo, A Cheng, ...
Gynecologic oncology 143 (1), 46-53, 2016
|Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy|
CS Lo, S Sanii, DR Kroeger, K Milne, A Talhouk, DS Chiu, K Rahimi, ...
Clinical Cancer Research 23 (4), 925-934, 2017
|Morphological and molecular characteristics of mixed epithelial ovarian cancers|
R Mackenzie, A Talhouk, S Eshragh, S Lau, D Cheung, C Chow, N Le, ...
The American journal of surgical pathology 39 (11), 1548, 2015
|Interobserver agreement in endometrial carcinoma histotype diagnosis varies depending on The Cancer Genome Atlas (TCGA)-based molecular subgroup|
LN Hoang, MA Kinloch, JM Leo, K Grondin, CH Lee, C Ewanowich, ...
The American journal of surgical pathology 41 (2), 245-252, 2017
|Efficient Bayesian inference for multivariate probit models with sparse inverse correlation matrices|
A Talhouk, A Doucet, K Murphy
Journal of Computational and Graphical Statistics 21 (3), 739-757, 2012
|Human papillomavirus (HPV)‐independent vulvar squamous cell carcinoma has a worse prognosis than HPV‐associated disease: a retrospective cohort study|
JN McAlpine, SCY Leung, A Cheng, D Miller, A Talhouk, CB Gilks, ...
Histopathology 71 (2), 238-246, 2017
|Molecularly defined adult granulosa cell tumor of the ovary: the clinical phenotype|
MK McConechy, A Färkkilä, HM Horlings, A Talhouk, L Unkila-Kallio, ...
JNCI: Journal of the National Cancer Institute 108 (11), 2016
|Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification|
AN Karnezis, S Leung, J Magrill, MK McConechy, W Yang, C Chow, ...
The Journal of Pathology: Clinical Research 3 (4), 279-293, 2017
|Pairwise network mechanisms in the host signaling response to coxsackievirus B3 infection|
FS Garmaroudi, D Marchant, X Si, A Khalili, A Bashashati, BW Wong, ...
Proceedings of the National Academy of Sciences 107 (39), 17053-17058, 2010
|Molecular subtype not immune response drives outcomes in endometrial carcinoma|
A Talhouk, H Derocher, P Schmidt, S Leung, K Milne, CB Gilks, ...
Clinical Cancer Research 25 (8), 2537-2548, 2019
|Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study|
PF Rambau, RA Vierkant, MP Intermaggio, LE Kelemen, MT Goodman, ...
The Journal of Pathology: Clinical Research 4 (4), 250-261, 2018
|Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma|
H Britton, L Huang, A Lum, S Leung, K Shum, M Kale, A Burleigh, J Senz, ...
Gynecologic oncology 153 (3), 487-495, 2019
|Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors|
A Burleigh, A Talhouk, CB Gilks, JN McAlpine
Gynecologic oncology 138 (1), 141-146, 2015